Dabuzalgron

DB20905ExperimentalSmall molecule

Dabuzalgron is a small molecule drug. Dabuzalgron has a monoisotopic molecular weight of 317.06 Da.

Mechanism: Pharmacologically active on Alpha-1A adrenergic receptor
Curator reviewed
Formula / weight: C₁₂H₁₆ClN₃O₃S · 317.79 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyFOYWMEJSRSBQGB-UHFFFAOYSA-NSMILESCC1=C(NS(C)(=O)=O)C(Cl)=CC=C1OCC1=NCCN1

Targets

What you can answer from here — as of September 13, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Dabuzalgron, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.